Busse, William W <br/><br/>
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Dec 2013 
 - 1294-302 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-4970 
<br/><br/><label>Standard No.: </label>10.1164/rccm.201212-2318OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--drug therapy<br/>Bronchi--drug effects<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Receptors, Interleukin-17--antagonists & inhibitors<br/>Young Adult